0001209191-23-035825.txt : 20230609 0001209191-23-035825.hdr.sgml : 20230609 20230609162034 ACCESSION NUMBER: 0001209191-23-035825 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230607 FILED AS OF DATE: 20230609 DATE AS OF CHANGE: 20230609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fischer Seth H. Z. CENTRAL INDEX KEY: 0001573553 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38899 FILM NUMBER: 231005566 MAIL ADDRESS: STREET 1: C/O TRIUS THERAPEUTICS, INC. STREET 2: 6310 NANCY RIDGE DRIVE, SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER NAME: FORMER CONFORMED NAME: Fischer Seth H.Z. DATE OF NAME CHANGE: 20130402 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Milestone Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001408443 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 CITY: MONTREAL STATE: A8 ZIP: H4M 2X6 BUSINESS PHONE: (514) 336-0444 MAIL ADDRESS: STREET 1: 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 CITY: MONTREAL STATE: A8 ZIP: H4M 2X6 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-07 0 0001408443 Milestone Pharmaceuticals Inc. MIST 0001573553 Fischer Seth H. Z. C/O MILESTONE PHARMACEUTICALS INC. 1111 DR. FREDERIK-PHILIPS BLVD, STE 420 MONTREAL A8 H4M 2X6 QUEBEC, CANADA 1 0 0 0 0 Stock Option (right to buy) 3.86 2023-06-07 4 A 0 30000 0.00 A 2033-06-07 Common Shares 30000 30000 D This option will vest in twelve (12) equal monthly installments, beginning on July 7, 2023, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. /s/ Jason Minio, Attorney-in-Fact 2023-06-09